These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29440192)

  • 1. Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement.
    Del Trigo M; Muñoz-García AJ; Latib A; Auffret V; Wijeysundera HC; Nombela-Franco L; Gutierrez E; Cheema AN; Serra V; Amat-Santos IJ; Kefer J; Benitez LM; Leclercq F; Mangieri A; Le Breton H; Jiménez-Quevedo P; Garcia Del Blanco B; Dager A; Abdul-Jawad Altisent O; Puri R; Pibarot P; Rodés-Cabau J
    Heart; 2018 May; 104(10):814-820. PubMed ID: 29440192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After Transcatheter Aortic Valve Replacement: Multicenter Registry.
    Del Trigo M; Muñoz-Garcia AJ; Wijeysundera HC; Nombela-Franco L; Cheema AN; Gutierrez E; Serra V; Kefer J; Amat-Santos IJ; Benitez LM; Mewa J; Jiménez-Quevedo P; Alnasser S; Garcia Del Blanco B; Dager A; Abdul-Jawad Altisent O; Puri R; Campelo-Parada F; Dahou A; Paradis JM; Dumont E; Pibarot P; Rodés-Cabau J
    J Am Coll Cardiol; 2016 Feb; 67(6):644-655. PubMed ID: 26868689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
    Huchet F; Letocart V; Guerin P; Cueff C; Roy-Giocosa J; Guyomarch-Delasalle B; Jaafar P; Manigold T
    Arch Cardiovasc Dis; 2018 Jan; 111(1):25-32. PubMed ID: 28943264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Transcatheter Aortic Valve Function With and Without Therapeutic Anticoagulation.
    Hiremath PG; Kearney K; Smith B; Don C; Dvir D; Aldea G; Reisman M; McCabe JM
    J Invasive Cardiol; 2017 Nov; 29(11):391-396. PubMed ID: 29086729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Jang MH; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Lee SA; Kim DH; Kim H; Choi Y; Lee J; Park SJ; Park DW
    Heart; 2023 Dec; 110(2):140-147. PubMed ID: 37586823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
    Vemulapalli S; Holmes DR; Dai D; Matsouaka R; Mack MJ; Grover FL; Makkar RR; Thourani VH; Douglas PS
    Am Heart J; 2018 Jan; 195():1-13. PubMed ID: 29224637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantation.
    Guedeney P; Huchet F; Manigold T; Overtchouk P; Rouanet S; Balagny P; Leprince P; Lebreton G; Letocart V; Barthelemy O; Vicaut E; Montalescot G; Guerin P; Collet JP;
    Arch Cardiovasc Dis; 2020 May; 113(5):341-349. PubMed ID: 32115397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leaflet thrombosis following transcatheter aortic valve implantation.
    Marwan M; Mekkhala N; Göller M; Röther J; Bittner D; Schuhbaeck A; Hell M; Muschiol G; Kolwelter J; Feyrer R; Schlundt C; Achenbach S; Arnold M
    J Cardiovasc Comput Tomogr; 2018; 12(1):8-13. PubMed ID: 29195844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
    Linke A; Chandrasekhar J; Sartori S; Lefevre T; van Belle E; Schaefer U; Tchetche D; Sardella G; Webb J; Colombo A; Windecker S; Vogel B; Farhan S; Sorrentino S; Sharma M; Snyder C; Asgar A; Dumonteil N; Tamburino C; Hink U; Violini R; Stella P; Bernstein D; Deliargyris E; Hengstenberg C; Baber U; Mehran R; Anthopoulos P; Dangas G;
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1016-1026. PubMed ID: 28498562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
    Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
    Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early hemodynamics and clinical outcomes of isolated aortic valve replacement with stentless or transcatheter valve in intermediate-risk patients.
    Repossini A; Di Bacco L; Passaretti B; Grubitzsch H; Schäfer C; Claus B; Giroletti L; Folliguet T; Bisleri G; Fischlein T; Santarpino G; Di Bartolomeo R; Laborde F; Muneretto C
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):549-558.e3. PubMed ID: 27939031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement.
    Chakravarty T; Patel A; Kapadia S; Raschpichler M; Smalling RW; Szeto WY; Abramowitz Y; Cheng W; Douglas PS; Hahn RT; Herrmann HC; Kereiakes D; Svensson L; Yoon SH; Babaliaros VC; Kodali S; Thourani VH; Alu MC; Liu Y; McAndrew T; Mack M; Leon MB; Makkar RR
    J Am Coll Cardiol; 2019 Sep; 74(9):1190-1200. PubMed ID: 31466616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic determinants of LV functional improvement after transcatheter aortic valve replacement.
    Chen J; Nawaz N; Fox Z; Komlo C; Anwaruddin S; Desai N; Jagasia D; Herrmann HC; Han Y
    Catheter Cardiovasc Interv; 2016 May; 87(6):1164-72. PubMed ID: 27145743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
    Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
    Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
    Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.
    Bleiziffer S; Bosmans J; Brecker S; Gerckens U; Wenaweser P; Tamburino C; Linke A;
    Clin Res Cardiol; 2017 Oct; 106(10):784-795. PubMed ID: 28484830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
    Deeb GM; Reardon MJ; Chetcuti S; Patel HJ; Grossman PM; Yakubov SJ; Kleiman NS; Coselli JS; Gleason TG; Lee JS; Hermiller JB; Heiser J; Merhi W; Zorn GL; Tadros P; Robinson N; Petrossian G; Hughes GC; Harrison JK; Maini B; Mumtaz M; Conte J; Resar J; Aharonian V; Pfeffer T; Oh JK; Qiao H; Adams DH; Popma JJ;
    J Am Coll Cardiol; 2016 Jun; 67(22):2565-74. PubMed ID: 27050187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.